SEC Form 4 · accession 0001645627-18-000068
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President
Period of report
Oct 23, 2018
Accepted (ET)
Oct 29, 2018 · 5:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 23, 2018 | P | 1,000 | $0.043 | A | 26,083,498 | D | |
| Common Stock | Oct 23, 2018 | P | 1,000 | $0.0424 | A | 26,084,498 | D | |
| Common Stock | Oct 23, 2018 | P | 1,000 | $0.0415 | A | 26,085,498 | D | |
| Common Stock | Oct 23, 2018 | P | 1,000 | $0.0424 | A | 26,086,498 | D | |
| Common Stock | Oct 23, 2018 | P | 1,000 | $0.0424 | A | 26,087,498 | D | |
| Common Stock | Oct 24, 2018 | P | 1,000 | $0.0422 | A | 26,088,498 | D | |
| Common Stock | Oct 26, 2018 | P | 2,000 | $0.0425 | A | 26,090,498 | D |
Table II — derivative securities
No Table II lines on this filing.